Risk factors for fingolimod-induced lymphopenia in multiple sclerosis

Background Lymphopenia is a well-known adverse event of fingolimod, a disease-modifying drug for multiple sclerosis (MS). Objectives The objective of this paper is to investigate risk factors for predicting fingolimod-induced lymphopenia in MS by frequent hematological monitoring. Methods We retrosp...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Multiple sclerosis journal - experimental, translational and clinical translational and clinical, 2018-01, Vol.4 (1), p.2055217318759692-2055217318759692
Hauptverfasser:	Ohtani, Ryohei, Mori, Masahiro, Uchida, Tomohiko, Uzawa, Akiyuki, Masuda, Hiroki, Liu, Jia, Kuwabara, Satoshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Multiple sclerosis Original Research Paper Risk factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!